These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17939336)

  • 21. Prevalence of abnormal serum 25-hydroxyvitamin D and its association with hemoglobin level in pre dialysis CKD patients: a cross-sectional study from Himalayan country.
    Sah SK; Adhikary LP
    BMC Nephrol; 2019 Jul; 20(1):267. PubMed ID: 31315585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study.
    Akizawa T; Tsubakihara Y; Hirakata H; Watanabe Y; Hase H; Nishi S; Babazono T; Kumagai M; Katakura S; Uemura Y; Ohashi Y;
    Clin Exp Nephrol; 2016 Dec; 20(6):885-895. PubMed ID: 26779906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
    Vikrant S
    Saudi J Kidney Dis Transpl; 2019; 30(4):932-942. PubMed ID: 31464252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.
    Tran L; Batech M; Rhee CM; Streja E; Kalantar-Zadeh K; Jacobsen SJ; Sim JJ
    Nephrol Dial Transplant; 2016 Apr; 31(4):636-45. PubMed ID: 26254460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease.
    Altemose KE; Kumar J; Portale AA; Warady BA; Furth SL; Fadrowski JJ; Atkinson MA
    Pediatr Nephrol; 2018 Nov; 33(11):2131-2136. PubMed ID: 30008129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and treatment of anemia with once-weekly epoetin alfa in patients with diabetes and chronic kidney disease.
    Lorber DL; Provenzano R; McClellan W
    Endocr Pract; 2006; 12(5):506-13. PubMed ID: 17002925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors for anemia in the early stages of chronic kidney disease].
    Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
    Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
    Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T
    Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-acting erythropoetin efficacy in the treatment of nephrogenic anemia in patients with chronic kidney disease during predialysis stage].
    Milovanov IuS; Milovanova LIu
    Ter Arkh; 2012; 84(6):48-52. PubMed ID: 22997919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Metabolism of Blood Manganese Is Associated with Low Levels of Hemoglobin in Patients with Chronic Kidney Disease.
    Kim M; Koh ES; Chung S; Chang YS; Shin SJ
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study.
    Yamamoto T; Miyazaki M; Nakayama M; Yamada G; Matsushima M; Sato M; Sato T; Taguma Y; Sato H; Ito S
    Clin Exp Nephrol; 2016 Aug; 20(4):595-602. PubMed ID: 26519375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between serum phosphate levels and anemia in non-dialysis patients with chronic kidney disease: a retrospective cross-sectional study from the Fuji City CKD Network.
    Kato K; Nakashima A; Ohkido I; Kasai K; Yokoo T
    BMC Nephrol; 2023 Aug; 24(1):244. PubMed ID: 37605118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Matsui A; Hirakata H
    Am J Nephrol; 2019; 49(2):165-174. PubMed ID: 30699415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
    Brigandi RA; Johnson B; Oei C; Westerman M; Olbina G; de Zoysa J; Roger SD; Sahay M; Cross N; McMahon L; Guptha V; Smolyarchuk EA; Singh N; Russ SF; Kumar S;
    Am J Kidney Dis; 2016 Jun; 67(6):861-71. PubMed ID: 26827289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study.
    Tsuruya K; Hayashi T; Yamamoto H; Hase H; Nishi S; Yamagata K; Nangaku M; Wada T; Uemura Y; Ohashi Y; Hirakata H;
    Clin Exp Nephrol; 2021 May; 25(5):456-466. PubMed ID: 33411115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease.
    Suzuki M; Hada Y; Akaishi M; Hiroe M; Aonuma K; Tsubakihara Y; Akizawa T
    Int Heart J; 2012; 53(4):238-43. PubMed ID: 22878802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients.
    Bakkaloğlu SA; Kandur Y; Serdaroğlu E; Noyan A; Bayazıt AK; Taşdemir M; Özlü SG; Özçelik G; Dursun İ; Alparslan C; Akcaboy M; Atikel YÖ; Parmaksız G; Atmış B; Sever L
    Pediatr Nephrol; 2018 Nov; 33(11):2143-2150. PubMed ID: 30105415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease.
    Navarro-González JF; Mora-Fernández C; Diaz-Tocados JM; Bozic M; Bermúdez-López M; Martín M; Valdivielso JM
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.